Millennium Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $165M | Buy |
1,180,760
+1,044,841
| +769% | +$146M | 0.07% | 261 |
|
|
2025
Q4 | $16.7M | Sell |
135,919
-496,770
| -79% | -$60.4M | 0.01% | 1744 |
|
|
2025
Q3 | $70.2M | Sell |
632,689
-131,459
| -17% | -$14.9M | 0.03% | 642 |
|
|
2025
Q2 | $84.7M | Sell |
764,148
-1,774,356
| -70% | -$189M | 0.04% | 490 |
|
|
2025
Q1 | $284M | Buy |
2,538,504
+1,855,995
| +272% | +$192M | 0.15% | 89 |
|
|
2024
Q4 | $63M | Sell |
682,509
-561,595
| -45% | -$50.6M | 0.03% | 651 |
|
|
2024
Q3 | $104M | Sell |
1,244,104
-1,296,086
| -51% | -$98.9M | 0.05% | 392 |
|
|
2024
Q2 | $174M | Buy |
2,540,190
+1,983,383
| +356% | +$132M | 0.08% | 231 |
|
|
2024
Q1 | $40.8M | Buy |
556,807
+519,402
| +1,389% | +$39.9M | 0.02% | 966 |
|
|
2023
Q4 | $3.03M | Sell |
37,405
-512,381
| -93% | -$39.9M | ﹤0.01% | 3233 |
|
|
2023
Q3 | $41.2M | Buy |
549,786
+402,417
| +273% | +$31M | 0.02% | 838 |
|
|
2023
Q2 | $11.4M | Sell |
147,369
-380,482
| -72% | -$30.3M | 0.01% | 1886 |
|
|
2023
Q1 | $43.8M | Sell |
527,851
-2,767,509
| -84% | -$229M | 0.03% | 778 |
|
|
2022
Q4 | $283M | Sell |
3,295,360
-77,474
| -2% | -$6.14M | 0.16% | 76 |
|
|
2022
Q3 | $208M | Buy |
3,372,834
+512,181
| +18% | +$32.3M | 0.12% | 94 |
|
|
2022
Q2 | $177M | Sell |
2,860,653
-1,102,159
| -28% | -$68.2M | 0.11% | 110 |
|
|
2022
Q1 | $236M | Buy |
3,962,812
+3,627,258
| +1,081% | +$232M | 0.12% | 84 |
|
|
2021
Q4 | $24.4M | Buy |
335,554
+74,482
| +29% | +$5.13M | 0.01% | 1273 |
|
|
2021
Q3 | $18.2M | Buy |
261,072
+159,060
| +156% | +$11.2M | 0.01% | 1419 |
|
|
2021
Q2 | $7.03M | Sell |
102,012
-1,465,356
| -93% | -$97.8M | ﹤0.01% | 2319 |
|
|
2021
Q1 | $101M | Sell |
1,567,368
-368,780
| -19% | -$23.8M | 0.07% | 229 |
|
|
2020
Q4 | $113M | Buy |
1,936,148
+1,820,911
| +1,580% | +$110M | 0.08% | 180 |
|
|
2020
Q3 | $7.28K | Sell |
115,237
-520,027
| -82% | -$36.1M | 0.01% | 1520 |
|
|
2020
Q2 | $48.9M | Buy |
635,264
+571,854
| +902% | +$43.8M | 0.07% | 298 |
|
|
2020
Q1 | $4.74M | Sell |
63,410
-1,251,286
| -95% | -$86.5M | 0.01% | 1369 |
|
|
2019
Q4 | $85.4M | Buy |
1,314,696
+1,271,277
| +2,928% | +$82.8M | 0.11% | 186 |
|
|
2019
Q3 | $2.75M | Sell |
43,419
-2,165,249
| -98% | -$142M | ﹤0.01% | 2230 |
|
|
2019
Q2 | $149M | Sell |
2,208,668
-1,745,720
| -44% | -$115M | 0.22% | 62 |
|
|
2019
Q1 | $257M | Sell |
3,954,388
-360,778
| -8% | -$24M | 0.38% | 18 |
|
|
2018
Q4 | $270M | Buy |
4,315,166
+2,576,875
| +148% | +$180M | 0.42% | 17 |
|
|
2018
Q3 | $134M | Buy |
1,738,291
+204,985
| +13% | +$15.5M | 0.16% | 121 |
|
|
2018
Q2 | $109M | Buy |
1,533,306
+171,621
| +13% | +$12.1M | 0.14% | 170 |
|
|
2018
Q1 | $103M | Buy |
1,361,685
+940,568
| +223% | +$74.8M | 0.14% | 177 |
|
|
2017
Q4 | $30.2M | Buy |
421,117
+141,345
| +51% | +$10.7M | 0.04% | 654 |
|
|
2017
Q3 | $22.7M | Sell |
279,772
-2,719,992
| -91% | -$208M | 0.03% | 718 |
|
|
2017
Q2 | $212M | Buy |
2,999,764
+1,103,698
| +58% | +$73.4M | 0.38% | 21 |
|
|
2017
Q1 | $129M | Buy |
1,896,066
+480,376
| +34% | +$33.8M | 0.24% | 67 |
|
|
2016
Q4 | $101M | Buy |
1,415,690
+521,323
| +58% | +$38.7M | 0.21% | 87 |
|
|
2016
Q3 | $70.8M | Sell |
894,367
-1,166,038
| -57% | -$94.7M | 0.12% | 169 |
|
|
2016
Q2 | $172M | Buy |
2,060,405
+1,313,798
| +176% | +$117M | 0.39% | 27 |
|
|
2016
Q1 | $68.6M | Sell |
746,607
-143,128
| -16% | -$12.9M | 0.17% | 120 |
|
|
2015
Q4 | $90M | Buy |
889,735
+97,485
| +12% | +$10.1M | 0.19% | 84 |
|
|
2015
Q3 | $77.8M | Buy |
792,250
+114,967
| +17% | +$12.8M | 0.15% | 135 |
|
|
2015
Q2 | $79.3M | Sell |
677,283
-294,652
| -30% | -$32.2M | 0.15% | 134 |
|
|
2015
Q1 | $95.4M | Sell |
971,935
-168,981
| -15% | -$17.2M | 0.18% | 104 |
|
|
2014
Q4 | $108M | Buy |
1,140,916
+448,623
| +65% | +$46.4M | 0.23% | 61 |
|
|
2014
Q3 | $73.7M | Sell |
692,293
-167,742
| -20% | -$16.4M | 0.19% | 100 |
|
|
2014
Q2 | $71.3M | Sell |
860,035
-33,826
| -4% | -$2.63M | 0.2% | 88 |
|
|
2014
Q1 | $63.3M | Sell |
893,861
-1,189,223
| -57% | -$93.3M | 0.18% | 101 |
|
|
2013
Q4 | $156M | Buy |
2,083,084
+1,745,152
| +516% | +$122M | 0.49% | 10 |
|
|
2013
Q3 | $21.2M | Sell |
337,932
-1,066,170
| -76% | -$63.7M | 0.07% | 324 |
|
|
2013
Q2 | $72M | Buy |
+1,404,102
| New | +$73.2M | 0.22% | 36 |
|
Other funds holding GILD
VCM
VPM
Millennium Management's GILD Position: Q1 2026 in Review
Millennium Management increased its Gilead Sciences (GILD) stake by 769% in Q1 2026, buying an estimated $146M and bringing the position to 1,180,760 shares worth $165M. The position accounts for 0.07% of the portfolio, ranked #261.
Millennium Management first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $284M in Q1 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Millennium Management held 1,180,760 shares of Gilead Sciences worth $165M as of Q1 2026.
- Millennium Management bought 1,044,841 Gilead Sciences shares in Q1 2026, an estimated $146M.
- Gilead Sciences made up 0.07% of Millennium Management's portfolio in Q1 2026, its #261 holding.
- Millennium Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
- Millennium Management's Gilead Sciences position peaked at $284M in Q1 2025.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.